-
1
-
-
79952390627
-
Immune parameters affecting the efficacy of chemotherapeutic regimens
-
Zitvogel L, Kepp O, Kroemer G. Immune parameters affecting the efficacy of chemotherapeutic regimens. Nat Rev Clin Oncol 2011; 8:151-60; http://dx.doi.org/10.1038/nrclinonc.2010.223
-
(2011)
Nat Rev Clin Oncol
, vol.8
, pp. 151-160
-
-
Zitvogel, L.1
Kepp, O.2
Kroemer, G.3
-
2
-
-
58249089749
-
Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer
-
Salama P, Phillips M, Grieu F, Morris M, Zeps N, Joseph D, et al. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 2009; 27:186-92; http://dx.doi.org/10.1200/JCO.2008.18.7229
-
(2009)
J Clin Oncol
, vol.27
, pp. 186-192
-
-
Salama, P.1
Phillips, M.2
Grieu, F.3
Morris, M.4
Zeps, N.5
Joseph, D.6
-
3
-
-
77954959667
-
Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy
-
Correale P, Rotundo MS, Del Vecchio MT, Remondo C, Migali C, Ginanneschi C, et al. Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy. J Immunother 2010; 33: 435-41; http://dx.doi.org/10.1097/CJI.0b013e3181d32f01
-
(2010)
J Immunother
, vol.33
, pp. 435-441
-
-
Correale, P.1
Rotundo, M.S.2
Del Vecchio, M.T.3
Remondo, C.4
Migali, C.5
Ginanneschi, C.6
-
4
-
-
84856545781
-
Tumour infiltration by T-lymphocytes expressing chemokine receptor 7 (CCR7) is predictive of favourable outcome in patients with advanced colorectal carcinoma
-
Epub ahead of print
-
Correale P, Rotundo MS, Botta C, Del Vecchio MT, Ginanneschi C, Licchetta A, et al. Tumour infiltration by T-lymphocytes expressing chemokine receptor 7 (CCR7) is predictive of favourable outcome in patients with advanced colorectal carcinoma. Clin Cancer Res 2012; Epub ahead of print; 18:850-7; http://dx.doi.org/10.1158/1078-0432.CCR-10-3186
-
(2012)
Clin Cancer Res;
, vol.18
, pp. 850-857
-
-
Correale, P.1
Rotundo, M.S.2
Botta, C.3
Del Vecchio, M.T.4
Ginanneschi, C.5
Licchetta, A.6
-
5
-
-
48249096809
-
Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial)
-
Correale P, Tagliaferri P, Fioravanti A, Del Vecchio MT, Remondo C, Montagnani F, et al. Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial). Clin Cancer Res 2008; 14:4192-9; http://dx.doi.org/10.1158/1078-0432.CCR-07-5278
-
(2008)
Clin Cancer Res
, vol.14
, pp. 4192-4199
-
-
Correale, P.1
Tagliaferri, P.2
Fioravanti, A.3
Del Vecchio, M.T.4
Remondo, C.5
Montagnani, F.6
-
6
-
-
79959742164
-
Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer
-
Ladoire S, Martin F, Ghiringhelli F. Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer. Cancer Immunol Immunother 2011; 60:909-18; http://dx.doi.org/10.1007/s00262-011-1046-y
-
(2011)
Cancer Immunol Immunother
, vol.60
, pp. 909-918
-
-
Ladoire, S.1
Martin, F.2
Ghiringhelli, F.3
-
7
-
-
81855166109
-
Tumor-associated*Macrophages (TAM) and Inflammation in Colorectal Cancer
-
Erreni M, Mantovani A, Allavena P. Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer. Cancer Microenviron 2011; 4:141-54; http://dx.doi.org/10.1007/s12307-010-0052-5
-
(2011)
Cancer Microenviron
, vol.4
, pp. 141-154
-
-
Erreni, M.1
Mantovani, A.2
Allavena, P.3
-
8
-
-
69249222379
-
Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN
-
Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L, et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell 2009; 16:183-94; http://dx.doi.org/10.1016/j.ccr.2009.06.017
-
(2009)
Cancer Cell
, vol.16
, pp. 183-194
-
-
Fridlender, Z.G.1
Sun, J.2
Kim, S.3
Kapoor, V.4
Cheng, G.5
Ling, L.6
|